Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
Neuroendocrine tumours (NETs) represent a heterogeneous family of neoplasms, which may develop from different endocrine glands (such as the pituitary, the parathyroid or the neuroendocrine adrenal glands), endocrine islets (within the thyroid or pancreas) as well as from endocrine cells dispersed be...
Main Authors: | Grozinsky-Glasberg, S, Shimon, I, Korbonits, M, Grossman, AB |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2008
|
פריטים דומים
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
מאת: Grozinsky-Glasberg, S, et al.
יצא לאור: (2008) -
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
מאת: Kaltsas, G, et al.
יצא לאור: (2005) -
Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
מאת: King, C, et al.
יצא לאור: (1993) -
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
מאת: Gupta, P, et al.
יצא לאור: (2014) -
Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
מאת: Ur, E, et al.
יצא לאור: (1993)